DE69837148D1 - Chimäre proteine zur behandlung von diabetes - Google Patents

Chimäre proteine zur behandlung von diabetes

Info

Publication number
DE69837148D1
DE69837148D1 DE69837148T DE69837148T DE69837148D1 DE 69837148 D1 DE69837148 D1 DE 69837148D1 DE 69837148 T DE69837148 T DE 69837148T DE 69837148 T DE69837148 T DE 69837148T DE 69837148 D1 DE69837148 D1 DE 69837148D1
Authority
DE
Germany
Prior art keywords
diabetes
treatment
chimeric proteins
chimeric
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69837148T
Other languages
English (en)
Other versions
DE69837148T2 (de
Inventor
John P Mueller
Louis A Matis
Yi Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alexion Pharmaceuticals Inc
Original Assignee
Alexion Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexion Pharmaceuticals Inc filed Critical Alexion Pharmaceuticals Inc
Publication of DE69837148D1 publication Critical patent/DE69837148D1/de
Application granted granted Critical
Publication of DE69837148T2 publication Critical patent/DE69837148T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69837148T 1997-12-23 1998-12-23 Chimäre proteine zur behandlung von diabetes Expired - Fee Related DE69837148T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6864897P 1997-12-23 1997-12-23
US68648P 1997-12-23
PCT/US1998/027408 WO1999032136A1 (en) 1997-12-23 1998-12-23 Chimeric proteins for the treatment of diabetes

Publications (2)

Publication Number Publication Date
DE69837148D1 true DE69837148D1 (de) 2007-04-05
DE69837148T2 DE69837148T2 (de) 2007-10-31

Family

ID=22083867

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69837148T Expired - Fee Related DE69837148T2 (de) 1997-12-23 1998-12-23 Chimäre proteine zur behandlung von diabetes

Country Status (6)

Country Link
EP (1) EP0999848B1 (de)
AU (1) AU2205099A (de)
CA (1) CA2318355A1 (de)
DE (1) DE69837148T2 (de)
ES (1) ES2283084T3 (de)
WO (1) WO1999032136A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770460B1 (en) * 1998-01-29 2004-08-03 Wallac Oy Fusion protein and its use in an immunoassay for the simultaneous detection of autoantibodies related to insulin-dependent diabetes mellitus
IL132611A0 (en) 1999-10-27 2001-03-19 Yeda Res & Dev Synthetic genes and polypeptides and pharmaceutical compositions comprising them
US8003595B2 (en) 2000-03-01 2011-08-23 Cellectis Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
US7049286B2 (en) 2001-08-30 2006-05-23 Diatos, S.A. Insulin conjugates and methods of use thereof
US7744876B2 (en) 2002-04-09 2010-06-29 The Curators Of The University Of Missouri Methods and compositions for treatment, prevention, suppression, and/or delaying the onset of type 1 diabetes
US8603471B2 (en) 2002-04-09 2013-12-10 The Curators Of The University Of Missouri Methods and compositions for preventing the onset of type 1 diabetes
ATE382367T1 (de) * 2002-04-09 2008-01-15 Univ Missouri Behandlung des typ 1 diabetes vor und nach expression von prädispositionsmarkern
US8603472B2 (en) 2002-04-09 2013-12-10 The Curators Of The University Of Missouri Methods and compositions reversing pre-diabetes using fusion proteins comprising a GAD peptide
WO2005018650A2 (fr) 2003-08-14 2005-03-03 Diatos Composition anti-bacterienne plus particulierement contre les bacteries gram negatif comprenent un peptide et un agent anti-bacterien avantageusement hydrophobe
WO2016161983A1 (zh) * 2015-04-10 2016-10-13 中国医学科学院药物研究所 一种融合载体蛋白及其在促进目的蛋白或多肽表达中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431740A (en) * 1979-09-12 1984-02-14 The Regents Of The University Of California DNA Transfer vector and transformed microorganism containing human proinsulin and pre-proinsulin genes
JP2564268B2 (ja) * 1985-08-28 1996-12-18 協和醗酵工業株式会社 融合抗原ポリペプチド
ES2318847T3 (es) * 1992-12-03 2009-05-01 The Regents Of The University Of California Metodos y reactivos mejorados para el diagnostico y el tratamiento de diabetes y del sindrome de stiff man.
ES2289751T3 (es) * 1995-02-20 2008-02-01 The Walter And Eliza Hall Institute Of Medical Research Moleculas inmunorreactivas e inmunoterapeuticas que interaccionan en sujetos con diabetes mellitus insulinodependientes (dmid).
US5821334A (en) * 1996-01-26 1998-10-13 Vanderbilt University Insulin-dependent diabetes mellitus-specific chimeric polypeptides
US6770460B1 (en) * 1998-01-29 2004-08-03 Wallac Oy Fusion protein and its use in an immunoassay for the simultaneous detection of autoantibodies related to insulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
AU2205099A (en) 1999-07-12
EP0999848A1 (de) 2000-05-17
CA2318355A1 (en) 1999-07-01
DE69837148T2 (de) 2007-10-31
EP0999848B1 (de) 2007-02-21
EP0999848A4 (de) 2003-03-05
WO1999032136A1 (en) 1999-07-01
ES2283084T3 (es) 2007-10-16

Similar Documents

Publication Publication Date Title
DE69817446D1 (de) Behandlung von diabetes
DE69812681D1 (de) Unsubstituierte polydiallylaminen zur behandlung von hypercholesterolemia
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE50009504D1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
DE69827424D1 (de) Vorrichtung zur gesteuerten thermischen Behandlung von Gewebe
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE292134T1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
ATA76995A (de) Stabiles präparat zur behandlung von blutgerinnungsstörungen
DE69840752D1 (de) Verwendung von coumarine zur behandlung von lebererkrankungen und pankreaserkrankungen
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69943089D1 (de) Methode zur behandlung von staphylokokkeninfektionen
DE69837148D1 (de) Chimäre proteine zur behandlung von diabetes
DE69829217D1 (de) Vorrichtung zur therapeutischen behandlung von blutgefässen
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
DE60001255T2 (de) Zusammensetzung zur Behandlung von Polyesterfaser
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
DE990441T1 (de) Arzneimittel zur behandlung von diabetischer nephrosis
DE69408394T2 (de) 4-Piperidino-piperidin zur Behandlung von Tumoren
ATE218866T1 (de) Kombinationstherapie zur behandlung von aids

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: MUELLER, JOHN, P., OLD LYME, CT 06371, US

Inventor name: MATIS, LOUIS, A., SOUTHPORT, CT 06490, US

Inventor name: WANG, YI, ORANGE, CT 06477, US

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee